Hong Kong After a challenging few years, the Hong Kong Stock Exchange (HKEX)’s IPO market bounced back strongly in 2025. By the end of Q3 2025, HK listings raised USD 23.9 billion across 66 IPOs (up 192 percent vs the previous year). Pre-revenue biotech listings, predominantly from mainland China, are also up…

MEA The Middle East and Africa (MEA) pharmaceutical market is booming. According to IQVIA, the market reached USD 32.6 billion in value last year with value sales growth at 10.5 percent versus the previous year. Saudi Arabia, the largest market in MEA at USD 11.6 billion in value, expanded at 9.1…

Europe Advanced Therapy Medicinal Products (ATMPs) – encompassing gene therapies, somatic-cell therapies, and tissue-engineered products – have been regulated in the European Union under a dedicated framework since 2009. As of 2025, the European Medicines Agency (EMA) has authorised close to 20 ATMPs (below), most of them gene therapies for rare…

China The top 20 Chinese pharma companies ranked by 2023 sales, according to the Citelie Scrip Asia 100. CSPC, Fosun, and Shanghai Pharma top the chart, with a host of other less well-known firms now also generating over a billion dollars in annual sales.   Made with Visme Infographic Maker

Switzerland 2024 marked a transformative year for Switzerland’s regulatory authority, Swissmedic. As part of its ambitious 2023–2026 strategy, the agency made significant strides towards digital transformation and improving access to innovative medicines while delivering a notable 12 percent increase in new drug approvals with 46 new active substances. Drive for Digital…

France The top 10 companies in the French retail generics market for 2024 according to Smart Pharma Consulting’s insights on the French pharma market. Last year, Viatris and Biogaran generated more than EUR 2.9 billion in sales and, taken together, represented over half of the total French retail generic market in…

Korea The Top 10 Korean pharma companies ranked by 2023 sales, as compiled in the latest Citeline Scrip Asia 100. Hanmi leads the way with USD 1.14 billion in sales, a 10 percent increase on the previous year, followed by Daewoong and Boryung. Made with Visme Infographic Maker  

China China’s National Reimbursement Drug List (NRDL) is the catalogue of medications covered under the country’s public health insurance system. The NRDL aims to enhance healthcare accessibility by subsidizing essential and innovative drugs, thereby reducing out-of-pocket expenses for patients. This 2023 edition of the list, released on December 13th 2023 and…

Italy The top 10 pharma manufacturing companies in Italy, as collated by MonitorItalia and ranked by production value in 2022. Pfizer tops the list, followed by Novartis, and local player Chiesi. The remainder of the list is populated by familiar names from multinational pharma, although another Italian firm – Alfasigma –…

Global The Top 10 medical device manufacturers for 2024 ranked by sales value for the past year. As compiled by Medical Product Outsourcing, Medtronic sits at the top of this year’s list with a full USD 32.36 billion in sales, driven primarily by organic rather than acquisition-based growth. J&J Medtech is…

Japan The Japan Exchange Group (JPX) is a key platform for both established companies and emerging bio ventures in Japan. Recently, it has focused on fostering innovation and growth in sectors like biotechnology through its Growth Market segment. This market is specifically designed for early-stage companies, providing them with an avenue…

Global Some of the key projections for the global use of medicines up to 2028, drawn from IQVIA’s report, The Global Use of Medicines 2024: Outlook to 2028. The report states that growth outlook has been raised by 2 percentage points despite lower expectations for COVID-19 vaccines and therapeutics. This increase in…